Chronic Pain
Chronic pain is one of the most researched areas of medical cannabis. Multiple clinical trials and meta-analyses have demonstrated meaningful pain reduction in patients with neuropathic, inflammatory and cancer-related pain.
Quick Reference
The Evidence Base
Chronic pain represents the most extensively studied application of medical cannabis. A landmark 2017 National Academies of Sciences review found conclusive evidence that cannabis is effective for the treatment of chronic pain in adults. Multiple systematic reviews and meta-analyses have confirmed that both THC and CBD, individually and in combination, produce clinically meaningful pain reductions compared to placebo. The effect is most pronounced in neuropathic pain conditions such as multiple sclerosis-related pain, HIV neuropathy, and chemotherapy-induced neuropathy.
How Cannabis Affects Pain
The endocannabinoid system plays a central role in pain modulation at multiple levels of the nervous system. CB1 receptors are densely expressed in pain-processing areas of the brain and spinal cord, where THC binds to produce analgesic effects. CBD modulates pain through several mechanisms including TRPV1 receptor activation, reduction of inflammatory cytokines, and enhancement of natural endocannabinoid tone. The combination of THC and CBD — the entourage effect — has demonstrated superior analgesic efficacy to either compound alone in several studies.
Types of Pain and Cannabis Response
Neuropathic pain (nerve damage, diabetes, MS, HIV) responds most strongly to cannabis-based medicine. Multiple clinical trials show 30–50% pain reduction in neuropathic patients. Inflammatory pain (arthritis, Crohn's, fibromyalgia) shows good response, particularly to CBD-dominant preparations due to their anti-inflammatory properties. Cancer pain and chemotherapy-related pain has strong evidence, with Sativex and dronabinol approved in multiple countries for this indication. Musculoskeletal pain has moderate evidence — cannabis may reduce pain and improve sleep in this population.
Recommended Approaches
For chronic pain, a balanced THC:CBD ratio (1:1) product such as Sativex has the strongest evidence base. CBD-only preparations show benefits for inflammatory pain with fewer psychoactive effects. For nightly pain management, an indica-dominant strain or THC-dominant preparation used at bedtime reduces pain while facilitating sleep. Oral preparations (oils, capsules) provide longer duration of action than inhalation, making them more suitable for sustained chronic pain management. Start with a very low THC dose and titrate slowly upward to the minimum effective dose.
Strains Associated With Pain Relief
High-myrcene strains are commonly associated with pain relief due to myrcene's reported analgesic and sedating properties. ACDC (very high CBD, low THC), Harlequin (CBD-dominant hybrid), Cannatonic (balanced), and Pennywise (high CBD indica) are popular medical options. For stronger pain with night-time use, high-THC indica strains such as OG Kush, Granddaddy Purple, and Bubba Kush are widely reported by patients. Individualised strain selection based on personal response remains the most effective approach.
Risks and Considerations
Cannabis dependence can develop with regular use. Cognitive effects, particularly memory impairment, occur with THC-dominant preparations. Drug interactions — cannabis inhibits CYP450 enzymes and can affect levels of blood thinners, anti-epileptics and other medications. High-THC preparations are contraindicated in personal or family history of psychosis. Cannabis should be used as part of a comprehensive pain management plan, not as a sole intervention. Always consult your prescribing physician before starting or adjusting cannabis-based medication.